Your browser doesn't support javascript.
loading
Duration of basic and attenuated-psychotic symptoms in individuals at clinical high risk for psychosis: pattern of symptom onset and effects of duration on functioning and cognition.
Staines, Lorna; Gajwani, Ruchika; Gross, Joachim; Gumley, Andrew I; Lawrie, Stephen M; Schwannauer, Matthias; Schultze-Lutter, Frauke; Uhlhaas, Peter J.
Afiliação
  • Staines L; Institute for Neuroscience and Psychology, University of Glasgow, Glasgow, UK.
  • Gajwani R; Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Gross J; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
  • Gumley AI; Institute for Neuroscience and Psychology, University of Glasgow, Glasgow, UK.
  • Lawrie SM; Institute for Biomagnetism and Biosignalanalysis, University of Muenster, Muenster, Germany.
  • Schwannauer M; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
  • Schultze-Lutter F; Department of Psychiatry, University of Edinburgh, Edinburgh, UK.
  • Uhlhaas PJ; Department of Clinical Psychology, University of Edinburgh, Edinburgh, UK.
BMC Psychiatry ; 21(1): 339, 2021 07 07.
Article em En | MEDLINE | ID: mdl-34233651
ABSTRACT

INTRODUCTION:

Duration of risk symptoms (DUR) in people at clinical high risk for psychosis (CHR-P) has been related to poorer clinical outcomes, such as reduced functioning, but it is currently unclear how different symptoms emerge as well as their link with cognitive deficits. To address these questions, we examined the duration of basic symptoms (BS) and attenuated psychotic symptoms (APS) in a sample of CHR-P participants to test the hypothesis that BS precede the manifestation of APS. As a secondary objective, we investigated the relationship between DUR, functioning and neuropsychological deficits.

METHODS:

Data from 134 CHR-P participants were assessed with the Comprehensive Assessment of At-Risk Mental State and the Schizophrenia Proneness Interview, Adult Version. Global, role and social functioning and neurocognition were assessed and compared to a sample of healthy controls (n = 57).

RESULTS:

In CHR-P participants who reported both APS and BS, onset of BS and APS was not significantly related. When divided into short and long BS duration ( 8 years), CHR-P participants with a longer duration of BS showed evidence for an onset of BS preceding APS (n = 8, p = 0.003). However, in the short BS duration group, APS showed evidence of preceding BS (n = 56, p = 0.020). Finally, there were no significant effects of DUR on cognition or functioning measures.

CONCLUSION:

The present findings do not support the view that APS constitute a secondary phenomenon to BS. Moreover, our data could also not confirm that DUR has a significant effect on functioning and cognitive deficits. These findings are discussed in the context of current theories regarding emerging psychosis and the importance of DUR.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Transtornos Cognitivos / Disfunção Cognitiva Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Transtornos Cognitivos / Disfunção Cognitiva Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article